Liposomes for gene transfer in cancer therapy.
We developed improved liposomes that produce efficacy for the treatment of cancer, cardiovascular diseases, and HIV-1-related diseases in small and large animal models. Because our processes are reproducible, we have standard operating procedures (SOPs) for the cGMP manufacture of these reagents that have been approved by the Food and Drug Administration for use in phase I/II clinical trials.
Templeton
Nancy Smyth
NS
Gradalis Inc., 2545 Golden Bear Drive, Suite 110, Carrollton, TX, 75006, USA.
D018014:Gene Transfer Techniques; D006801:Humans; D008081:Liposomes / Q000378:metabolism*; D009369:Neoplasms / Q000628:therapy*; D011786:Quality Control
D008081:Liposomes